ANCHOR LEAD: WHY HAS THE FDA ANNOUNCED INCREASED OVERSIGHT OF BOTOX? ELIZABETH TRACEY REPORTS
An increased number of adverse events and deaths following Botox injection has prompted the FDA to announce it will be scrutinizing the popular wrinkle treatment more closely. Rebecca Kazin, director of the Johns Hopkins Cosmetic Center, explains.
KAZIN: The good news about Botox is it has a very long safety track record. We’ve actually been injecting Botox for over twenty years, but what everyone needs to know is that we use it for medical as well as cosmetic purposes, and a lot of the concern has been for more medical purposes in children who have cerebral palsy and limb spasticity. Many times in those children you’re using higher dosages of medications and its more of an experimental procedure, and with any procedure like that the physician and patient and the parent need to discuss the risks and benefits and they need to be understood. :31
Kazin says people considering Botox should make sure their physician has experience and is using the right formulation. I’m Elizabeth Tracey reporting.